Latest Off-label use Stories
FDA marketing scrutiny no longer is limited to magazine and TV ads.
Expert dermatologist Dr.
Over Three-Quarters of Physicians View Ophthotech's Fovista as an Emerging Therapy with High Potential Value for Wet AMD, According to Findings from Decision Resources Group BURLINGTON, Mass.,
The GlaxoSmithKline settlement involves the District of Columbia and 44 states over the marketing of Advair, Paxil, and Wellbutrin. Port Washington, NY (PRWEB)
National network of attorneys will continue to offer complimentary consultations to consumers of all ages who may be seeking compensation over allegations of gynecomastia and other side effects.
NEW YORK, April 21, 2014 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) announces a $190
No-cost consultations from a national network of attorneys are now available to consumers of all ages who may be seeking compensation over allegations of gynecomastia, other side effects.
National network of attorneys initiates offer of no-cost consultations to consumers seeking compensation for allegations of gynecomastia, other side effects. San
The U.S. Food and Drug Administration reports it has notified health professionals about a new Black Box warning for Pfizer Inc.'s intravenous antibacterial drug Tygacil (tigecycline).
- A transitional zone between two communities containing the characteristic species of each.